- Home
- MLYS vs DGII Comparison
MLYS vs DGII Comparison
Compare MLYS & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- DGII
- Stock Information
- Founded
- MLYS 2019
- DGII 1985
- Country
- MLYS United States
- DGII United States
- Employees
- MLYS N/A
- DGII N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- DGII Computer peripheral equipment
- Sector
- MLYS Health Care
- DGII Technology
- Exchange
- MLYS Nasdaq
- DGII Nasdaq
- Market Cap
- MLYS 1.0B
- DGII 976.7M
- IPO Year
- MLYS 2023
- DGII N/A
- Fundamental
- Price
- MLYS $15.58
- DGII $32.41
- Analyst Decision
- MLYS Strong Buy
- DGII Hold
- Analyst Count
- MLYS 3
- DGII 4
- Target Price
- MLYS $33.00
- DGII $33.50
- AVG Volume (30 Days)
- MLYS 866.7K
- DGII 179.4K
- Earning Date
- MLYS 05-12-2025
- DGII 05-07-2025
- Dividend Yield
- MLYS N/A
- DGII N/A
- EPS Growth
- MLYS N/A
- DGII 196.64
- EPS
- MLYS N/A
- DGII 1.13
- Revenue
- MLYS N/A
- DGII $418,624,000.00
- Revenue This Year
- MLYS N/A
- DGII $1.81
- Revenue Next Year
- MLYS N/A
- DGII $4.30
- P/E Ratio
- MLYS N/A
- DGII $28.73
- Revenue Growth
- MLYS N/A
- DGII N/A
- 52 Week Low
- MLYS $8.24
- DGII $20.17
- 52 Week High
- MLYS $18.38
- DGII $37.07
- Technical
- Relative Strength Index (RSI)
- MLYS 54.41
- DGII 59.92
- Support Level
- MLYS $15.45
- DGII $32.51
- Resistance Level
- MLYS $16.11
- DGII $33.18
- Average True Range (ATR)
- MLYS 0.96
- DGII 0.68
- MACD
- MLYS -0.05
- DGII -0.14
- Stochastic Oscillator
- MLYS 51.56
- DGII 36.48
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.